Correlation Between Evogene and Enlivex Therapeutics
Can any of the company-specific risk be diversified away by investing in both Evogene and Enlivex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evogene and Enlivex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evogene and Enlivex Therapeutics, you can compare the effects of market volatilities on Evogene and Enlivex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evogene with a short position of Enlivex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evogene and Enlivex Therapeutics.
Diversification Opportunities for Evogene and Enlivex Therapeutics
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Evogene and Enlivex is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Evogene and Enlivex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enlivex Therapeutics and Evogene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evogene are associated (or correlated) with Enlivex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enlivex Therapeutics has no effect on the direction of Evogene i.e., Evogene and Enlivex Therapeutics go up and down completely randomly.
Pair Corralation between Evogene and Enlivex Therapeutics
Given the investment horizon of 90 days Evogene is expected to generate 1.54 times more return on investment than Enlivex Therapeutics. However, Evogene is 1.54 times more volatile than Enlivex Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Enlivex Therapeutics is currently generating about -0.17 per unit of risk. If you would invest 155.00 in Evogene on December 1, 2024 and sell it today you would lose (8.00) from holding Evogene or give up 5.16% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 85.71% |
| Values | Daily Returns |
Evogene vs. Enlivex Therapeutics
Performance |
| Timeline |
| Evogene |
| Enlivex Therapeutics |
Evogene and Enlivex Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Evogene and Enlivex Therapeutics
The main advantage of trading using opposite Evogene and Enlivex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evogene position performs unexpectedly, Enlivex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enlivex Therapeutics will offset losses from the drop in Enlivex Therapeutics' long position.| Evogene vs. Arcus Biosciences | Evogene vs. Fate Therapeutics | Evogene vs. Pluri Inc | Evogene vs. Lexaria Bioscience Corp |
| Enlivex Therapeutics vs. Scope Metals Group | Enlivex Therapeutics vs. Inrom Construction Industries | Enlivex Therapeutics vs. Electreon Wireless | Enlivex Therapeutics vs. Gilat Telecom Global |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |